155 related articles for article (PubMed ID: 31347045)
61. Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry.
Mnatsakanyan R; Shema G; Basik M; Batist G; Borchers CH; Sickmann A; Zahedi RP
Expert Rev Proteomics; 2018 Jun; 15(6):515-535. PubMed ID: 29893147
[TBL] [Abstract][Full Text] [Related]
62. Advances in crop proteomics: PTMs of proteins under abiotic stress.
Wu X; Gong F; Cao D; Hu X; Wang W
Proteomics; 2016 Mar; 16(5):847-65. PubMed ID: 26616472
[TBL] [Abstract][Full Text] [Related]
63. Application of mass spectrometry in proteomics.
Guerrera IC; Kleiner O
Biosci Rep; 2005; 25(1-2):71-93. PubMed ID: 16222421
[TBL] [Abstract][Full Text] [Related]
64. Stable isotope labeling by fatty acids in cell culture (SILFAC) coupled with isotope pattern dependent mass spectrometry for global screening of lipid hydroperoxide-mediated protein modifications.
Takahashi R; Fujioka S; Oe T; Lee SH
J Proteomics; 2017 Aug; 166():101-114. PubMed ID: 28735093
[TBL] [Abstract][Full Text] [Related]
65. Quantitative analysis of protein-protein interactions and post-translational modifications in rare immune populations.
Avin A; Levy M; Porat Z; Abramson J
Nat Commun; 2017 Nov; 8(1):1524. PubMed ID: 29142256
[TBL] [Abstract][Full Text] [Related]
66. Comprehensive identification of novel post-translational modifications in cellular peroxiredoxin 6.
Jeong J; Kim Y; Kyung Seong J; Lee KJ
Proteomics; 2012 May; 12(9):1452-62. PubMed ID: 22589192
[TBL] [Abstract][Full Text] [Related]
67. Unraveling the histone's potential: a proteomics perspective.
Brumbaugh J; Phanstiel D; Coon JJ
Epigenetics; 2008 Sep; 3(5):254-7. PubMed ID: 18849650
[TBL] [Abstract][Full Text] [Related]
68. iTop-Q: an Intelligent Tool for Top-down Proteomics Quantitation Using DYAMOND Algorithm.
Chang HY; Chen CT; Ko CL; Chen YJ; Chen YJ; Hsu WL; Juo CG; Sung TY
Anal Chem; 2017 Dec; 89(24):13128-13136. PubMed ID: 29165996
[TBL] [Abstract][Full Text] [Related]
69. Existing bioinformatics tools for the quantitation of post-translational modifications.
Allmer J
Amino Acids; 2012 Jan; 42(1):129-38. PubMed ID: 20473535
[TBL] [Abstract][Full Text] [Related]
70. Effect of posttranslational modifications on enzyme function and assembly.
Ryšlavá H; Doubnerová V; Kavan D; Vaněk O
J Proteomics; 2013 Oct; 92():80-109. PubMed ID: 23603109
[TBL] [Abstract][Full Text] [Related]
71. A Critical Review of Bottom-Up Proteomics: The Good, the Bad, and the Future of this Field.
Dupree EJ; Jayathirtha M; Yorkey H; Mihasan M; Petre BA; Darie CC
Proteomes; 2020 Jul; 8(3):. PubMed ID: 32640657
[TBL] [Abstract][Full Text] [Related]
72. Proteomic research: potential opportunities for clinical and physiological investigators.
Nair KS; Jaleel A; Asmann YW; Short KR; Raghavakaimal S
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E863-74. PubMed ID: 15140753
[TBL] [Abstract][Full Text] [Related]
73. Technologies for the identification and validation of protein-protein interactions.
Pichlerova K; Hanes J
Gen Physiol Biophys; 2021 Nov; 40(6):495-522. PubMed ID: 34897023
[TBL] [Abstract][Full Text] [Related]
74. Uncovering biology by single-cell proteomics.
Mansuri MS; Williams K; Nairn AC
Commun Biol; 2023 Apr; 6(1):381. PubMed ID: 37031277
[TBL] [Abstract][Full Text] [Related]
75. A bifunctional amino acid to study protein-protein interactions.
Yang T; Li X; Li XD
RSC Adv; 2020 Nov; 10(69):42076-42083. PubMed ID: 35516754
[TBL] [Abstract][Full Text] [Related]
76. Protein modifications and diseases.
Tang S
J Cell Physiol; 2024 Mar; 239(3):e31194. PubMed ID: 38230572
[No Abstract] [Full Text] [Related]
77. Peter Riederer, a translational neurobiochemist.
Nagatsu T; Reichmann H
J Neural Transm (Vienna); 2022 Jun; 129(5-6):443-444. PubMed ID: 35389106
[No Abstract] [Full Text] [Related]
78. Translational Neurodegeneration in the era of fast growing international brain research.
Zheng JC; Chen S
Transl Neurodegener; 2022 Jan; 11(1):1. PubMed ID: 34974845
[No Abstract] [Full Text] [Related]
79. Proteomics.
Banker DD
Indian J Med Sci; 2002 Jan; 56(1):22-4. PubMed ID: 12508628
[No Abstract] [Full Text] [Related]
80. Clinical Proteomics: From Biological Sample to Clinical Exploitation.
Lasonder E
Proteomes; 2017 Apr; 5(2):. PubMed ID: 28383478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
